Skip to main content

Venrock — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

156
Companies
$8.0B
Total invested
$54.9M
Avg. check
45
Industries
Biotechnology 12Health Care 9Medical 7Software 5Therapeutics 5Artificial Intelligence (AI) 4+39 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–144 of 156
Nightfall
August 2022

Nightfall is a cloud data protection platform that uses machine learning to identify and detect business-critical data.

Analytics · San Francisco$40.0M Series B
Dgraph Labs
July 2022

Dgraph is a fast, transactional, native and distributed graph database.

San Francisco$6.0M Seed
Arch Data, Inc (fka Meltano)
June 2022

Arch transforms data into decisions with your AI Data Analyst—a unified, intelligent platform for analytics and insights, backed by experts.

Data Integration · Austin$8.2M Seed
Kelonia Therapeutics
April 2022

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Biotechnology · Boston$50.0M Series A
Decodable
February 2022

Decodable is a serverless data integration and engineering platform for streaming data.

Developer Platform · San Francisco$20.0M Series A
Socrates.AI, Inc.
February 2022

Socrates AI brings deep expertise in Artificial Intelligence.

Artificial Intelligence (AI) · San FranciscoSeries A
Concentric Analgesics
January 2022

Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.

Biotechnology · San Francisco$20.0M Convertible Note
Mythic Therapeutics
December 2021

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Biotechnology · Waltham$103.0M Series B
Ablaze Pharmaceuticals
November 2021

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

Biotechnology · Jingan$75.0M Series A
Stride Health
October 2021

Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services.

Employee Benefits · San Francisco$47.0M Series C
Rebellion Defense
September 2021

Rebellion Defense's mission is to help the US and its partners outpace tomorrow's adversary.

Artificial Intelligence (AI) · Washington$150.0M Series B
Rarible
June 2021

Rarible is a community-centric NFT marketplace and infrastructure provider

Blockchain · Wilmington$14.2M Series A
percipient.ai
April 2021

Percipient.ai is a provider of an artificial intelligence advanced analytics platform designed to provide solutions for Intelligence.

Analytics · Santa Clara$50.0M Series C
Encoded Therapeutics
March 2021

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Biotechnology · South San FranciscoSeries D
Cyteir Therapeutics
February 2021

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

Biopharma · Cambridge$80.0M Series C
Beckon
December 2020

Beckon provides data management and real-time marketing intelligence for better, faster decisions to grow your brand.

Analytics · San Mateo$290K Series Unknown
Federation Bio
October 2020

Federation Bio is a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role.

Biotechnology · South San Francisco$50.0M Series A
PROPS
April 2020

PROPS creates a decentralized model for digital media that uses blockchain technology to reward the contributors that power the network.

Advertising · New York$2.0M Initial Coin Offering
Corvidia
March 2020

Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.

Biotechnology · Waltham$827K Convertible Note
10X Genomics
January 2020

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

Biotechnology · PleasantonPost Ipo Equity
Attune Pharmaceuticals
January 2019

Attune Pharmaceuticals is a private biotechnology company.

Biotechnology · New York$23.0M Series B
Sojournix
January 2019

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

Biotechnology · Arlington$44.0M Series C
Workframe
May 2018

The workflow optimization platform for commercial real estate professionals

Collaboration · New York$9.5M Series B
Hua Medicine
March 2018

Hua Medicine is a clinical-stage, innovative drug development company in China.

Biotechnology · ShanghaiSeries E

Where Venrock invests

Biotechnology12
Health Care9
Medical7
Software5
Therapeutics5
Artificial Intelligence (AI)4

About Venrock's portfolio

How many companies has Venrock invested in?▸

Venrock has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venrock invest in?▸

Venrock's top investment sectors include Biotechnology, Health Care, Medical, Software, Therapeutics. The firm invests across 45 different industry categories.

What is Venrock's largest investment?▸

Among tracked funding rounds, Rebellion Defense received $150.0M in a Series B round. Venrock's total known invested capital is $8.0B.

What is the average investment size for Venrock?▸

Venrock's average investment size is $54.9M across its portfolio of 156 companies.

What are Venrock's most recent investments?▸

Recent Venrock portfolio additions include Nightfall, Dgraph Labs, Arch Data, Inc (fka Meltano), Kelonia Therapeutics, Decodable. These companies were founded in 2020 or later.

Reach the founders behind these 156 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →